These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 38339985)
21. Carbamazepine versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Tudur Smith C Cochrane Database Syst Rev; 2019 Jul; 7(7):CD001911. PubMed ID: 31318037 [TBL] [Abstract][Full Text] [Related]
22. New-onset status epilepticus and cluster seizures in the elderly. Sinha S; Satishchandra P; Kalband BR; Thennarasu K J Clin Neurosci; 2013 Mar; 20(3):423-8. PubMed ID: 23313529 [TBL] [Abstract][Full Text] [Related]
23. Status epilepticus and acute repetitive seizures in children, adolescents, and young adults: etiology, outcome, and treatment. Mitchell WG Epilepsia; 1996; 37 Suppl 1():S74-80. PubMed ID: 8647055 [TBL] [Abstract][Full Text] [Related]
24. Sodium valproate versus phenytoin monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2018 Aug; 8(8):CD001769. PubMed ID: 30091458 [TBL] [Abstract][Full Text] [Related]
25. Carbamazepine versus phenobarbitone monotherapy for epilepsy: an individual participant data review. Nolan SJ; Marson AG; Weston J; Tudur Smith C Cochrane Database Syst Rev; 2015 Jul; (7):CD001904. PubMed ID: 26204241 [TBL] [Abstract][Full Text] [Related]
26. Refractory status epilepticus: a developing country perspective. Sinha S; Prashantha DK; Thennarasu K; Umamaheshwara Rao GS; Satishchandra P J Neurol Sci; 2010 Mar; 290(1-2):60-5. PubMed ID: 19954801 [TBL] [Abstract][Full Text] [Related]
27. Lamotrigine versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nevitt SJ; Tudur Smith C; Weston J; Marson AG Cochrane Database Syst Rev; 2018 Jun; 6(6):CD001031. PubMed ID: 29952431 [TBL] [Abstract][Full Text] [Related]
28. Predictive factors of Status Epilepticus and its recurrence in patients with adult-onset seizures: A multicenter, long follow-up cohort study. Gasparini S; Ferlazzo E; Gigli G; Pauletto G; Nilo A; Lettieri C; Bilo L; Labate A; Fortunato F; Varrasi C; Cantello R; D'Aniello A; Gennaro GD; d'Orsi G; Sabetta A; Claudio MTD; Avolio C; Dono F; Evangelista G; Cavalli SM; Cianci V; Ascoli M; Mastroianni G; Lobianco C; Neri S; Mercuri S; Mammì A; Gambardella A; Beghi E; Torino C; Tripepi G; Aguglia U; Seizure; 2021 Oct; 91():397-401. PubMed ID: 34298459 [TBL] [Abstract][Full Text] [Related]
29. Predictors and outcome of status epilepticus in cerebral venous thrombosis. Kalita J; Misra UK; Singh VK; Dubey D J Neurol; 2019 Feb; 266(2):417-425. PubMed ID: 30569383 [TBL] [Abstract][Full Text] [Related]
30. Intravenous levetiracetam in acute repetitive seizures and status epilepticus in children: experience from a children's hospital. McTague A; Kneen R; Kumar R; Spinty S; Appleton R Seizure; 2012 Sep; 21(7):529-34. PubMed ID: 22722010 [TBL] [Abstract][Full Text] [Related]
31. Prognosis of status epilepticus (SE): Relationship between SE duration and subsequent development of epilepsy. Santamarina E; Gonzalez M; Toledo M; Sueiras M; Guzman L; Rodríguez N; Quintana M; Mazuela G; Salas-Puig X Epilepsy Behav; 2015 Aug; 49():138-40. PubMed ID: 26117525 [TBL] [Abstract][Full Text] [Related]
32. Immediate antiepileptic drug treatment, versus placebo, deferred, or no treatment for first unprovoked seizure. Leone MA; Giussani G; Nevitt SJ; Marson AG; Beghi E Cochrane Database Syst Rev; 2021 May; 5(5):CD007144. PubMed ID: 33942281 [TBL] [Abstract][Full Text] [Related]
33. Pediatric status epilepticus: a perspective from Saudi Arabia. Mah JK; Mah MW Pediatr Neurol; 1999 May; 20(5):364-9. PubMed ID: 10371382 [TBL] [Abstract][Full Text] [Related]
34. Seizure recurrence after a first unprovoked seizure in childhood: a prospective study. Ramos Lizana J; Cassinello Garciá E; Carrasco Marina LL; Vázquez López M; Martín González M; Muñoz Hoyos A Epilepsia; 2000 Aug; 41(8):1005-13. PubMed ID: 10961628 [TBL] [Abstract][Full Text] [Related]
35. Prognosticating acute symptomatic seizures using two different seizure outcomes. Leung H; Man CB; Hui AC; Kwan P; Wong KS Epilepsia; 2010 Aug; 51(8):1570-9. PubMed ID: 20002147 [TBL] [Abstract][Full Text] [Related]
36. Topiramate versus carbamazepine monotherapy for epilepsy: an individual participant data review. Nolan SJ; Sudell M; Tudur Smith C; Marson AG Cochrane Database Syst Rev; 2016 Dec; 12(12):CD012065. PubMed ID: 27922722 [TBL] [Abstract][Full Text] [Related]
37. A new derivative of valproic acid amide possesses a broad-spectrum antiseizure profile and unique activity against status epilepticus and organophosphate neuronal damage. White HS; Alex AB; Pollock A; Hen N; Shekh-Ahmad T; Wilcox KS; McDonough JH; Stables JP; Kaufmann D; Yagen B; Bialer M Epilepsia; 2012 Jan; 53(1):134-46. PubMed ID: 22150444 [TBL] [Abstract][Full Text] [Related]
38. Timing matters: there are significant differences in short-term outcomes between two time points of status epilepticus. Pan Y; Feng Y; Peng W; Cai Y; Ding J; Wang X BMC Neurol; 2022 Sep; 22(1):348. PubMed ID: 36104657 [TBL] [Abstract][Full Text] [Related]
39. Latency to treatment of status epilepticus is associated with mortality and functional status. Cheng JY J Neurol Sci; 2016 Nov; 370():290-295. PubMed ID: 27772779 [TBL] [Abstract][Full Text] [Related]
40. Response: "What is the risk of unprovoked seizures after acute symptomatic status epilepticus?". Santamarina E; Rodrigo-Gisbert M; Abraira L; Campos-Fernández D; Quintana M; Gómez-Dabó L; Fonseca E; Lallana S; Toledo M Epilepsia; 2023 Dec; 64(12):3410-3411. PubMed ID: 37804071 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]